These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
582 related items for PubMed ID: 25871903
21. Cell therapy in bisphosphonate-related osteonecrosis of the jaw. Gonzálvez-García M, Rodríguez-Lozano FJ, Villanueva V, Segarra-Fenoll D, Rodríguez-González MA, Oñate-Sánchez R, Blanquer M, Moraleda JM. J Craniofac Surg; 2013 May; 24(3):e226-8. PubMed ID: 23714970 [Abstract] [Full Text] [Related]
22. Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan. Urade M, Tanaka N, Furusawa K, Shimada J, Shibata T, Kirita T, Yamamoto T, Ikebe T, Kitagawa Y, Fukuta J. J Oral Maxillofac Surg; 2011 Nov; 69(11):e364-71. PubMed ID: 21782307 [Abstract] [Full Text] [Related]
23. What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics. Freiberger JJ, Padilla-Burgos R, McGraw T, Suliman HB, Kraft KH, Stolp BW, Moon RE, Piantadosi CA. J Oral Maxillofac Surg; 2012 Jul; 70(7):1573-83. PubMed ID: 22698292 [Abstract] [Full Text] [Related]
24. Medication-related osteonecrosis of the jaws from once per year intravenous zoledronic acid (Reclast): report of 4 cases. Lee CY, Suzuki JB. Implant Dent; 2015 Apr; 24(2):227-31. PubMed ID: 25734948 [Abstract] [Full Text] [Related]
26. Fluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw: A prospective cohort study. Otto S, Ristow O, Pache C, Troeltzsch M, Fliefel R, Ehrenfeld M, Pautke C. J Craniomaxillofac Surg; 2016 Aug; 44(8):1073-80. PubMed ID: 27263757 [Abstract] [Full Text] [Related]
27. Medication-related osteonecrosis of the jaw after once-a-year intravenous zoledronic acid infusion for osteoporosis: Report of eight cases. Favia G, Tempesta A, Limongelli L, Crincoli V, Maiorano E. Quintessence Int; 2016 Aug; 47(5):433-40. PubMed ID: 26665262 [Abstract] [Full Text] [Related]
28. Nasolabial Flap Improves Healing in Medication-Related Osteonecrosis of the Jaw. Lemound J, Muecke T, Zeller AN, Lichtenstein J, Eckardt A, Gellrich NC. J Oral Maxillofac Surg; 2018 Apr; 76(4):877-885. PubMed ID: 29104029 [Abstract] [Full Text] [Related]
29. Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma. Diego R, D'Orto O, Pagani D, Agazzi A, Marzano U, Derada Troletti G, Fontanella W, Pignataro L. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e1-5. PubMed ID: 17197204 [Abstract] [Full Text] [Related]
30. [Surgical treatment of maxillary osteonecrosis due to bisphosphonates using an Er:YAG (2940 nm) laser. Discussion of 17 clinical cases]. Vescovi P, Merigo E, Manfredi M, Meleti M, Fornaini C, Bonanini M, Rocca EP, De Moor RJ, Nammour S. Rev Belge Med Dent (1984); 2009 Mar; 64(2):87-95. PubMed ID: 19681350 [Abstract] [Full Text] [Related]
31. Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents. Hauer L, Jambura J, Hrusak D, Chalupova M, Posta P, Rusnak S, Vyskocil V. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):100-107. PubMed ID: 30647474 [Abstract] [Full Text] [Related]
32. Influence of dentures in the initial occurrence site on the prognosis of bisphosphonate-related osteonecrosis of the jaws: a retrospective study. Hasegawa Y, Kawabe M, Kimura H, Kurita K, Fukuta J, Urade M. Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Sep; 114(3):318-24. PubMed ID: 22862971 [Abstract] [Full Text] [Related]
33. Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study. Scoletta M, Arduino PG, Dalmasso P, Broccoletti R, Mozzati M. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jul; 110(1):46-53. PubMed ID: 20452252 [Abstract] [Full Text] [Related]
34. Bisphosphonate-related osteonecrosis of the jaws--a case report. Kamoh AK, Ogle O. Compend Contin Educ Dent; 2012 May; 33(5):e74-7. PubMed ID: 23268588 [Abstract] [Full Text] [Related]
35. Bisphosphonate-associated osteonecrosis of the jaws: surgical treatment with ErCrYSGG-laser. Case report. Rugani P, Acham S, Truschnegg A, Obermayer-Pietsch B, Jakse N. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Dec; 110(6):e1-6. PubMed ID: 21112522 [Abstract] [Full Text] [Related]
37. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. Carlson ER, Basile JD. J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819 [Abstract] [Full Text] [Related]
38. Surgical and conservative treatment outcomes of medication-related osteonecrosis of the jaw located at tori: a retrospective study. Amin H, Andersen SWM, Jensen SS, Kofod T. Oral Maxillofac Surg; 2024 Sep; 28(3):1117-1125. PubMed ID: 38418702 [Abstract] [Full Text] [Related]
39. Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study. Pautke C, Bauer F, Otto S, Tischer T, Steiner T, Weitz J, Kreutzer K, Hohlweg-Majert B, Wolff KD, Hafner S, Mast G, Ehrenfeld M, Stürzenbaum SR, Kolk A. J Oral Maxillofac Surg; 2011 Jan; 69(1):84-91. PubMed ID: 20971542 [Abstract] [Full Text] [Related]
40. Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients. Lazarovici TS, Yahalom R, Taicher S, Elad S, Hardan I, Yarom N. J Oral Maxillofac Surg; 2009 Apr; 67(4):850-5. PubMed ID: 19304045 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]